Results 91 to 100 of about 1,058 (155)
Introducción: El telmisartan es un ARA II con unas características propias que nos permite obtener unos beneficios adicionales. Además de bloquear el receptor I de la angiotensina II, va actuar a través de receptores nucleares claves como el receptor ...
J. L. Pérez-Castrillón +7 more
doaj
A large multicentre study involving 6003 [3044 males, 2959 females; mean (+/- SD) age 59 +/- 11 years] mild-to-severe hypertensive patients was carried out to evaluate the effects of the angiotension converting enzyme inhibitor quinapril on blood ...
MANZATO, ENZO, CAPURSO A, CREPALDI G.
core
Quinapril Overdose-Induced Renal Failure
Suchard, Jeffrey R, Bearie, Brian J
doaj
Benefit and Risk Evaluation of Quinapril Hydrochloride
INTRODUCTION: Angiotensin-converting enzyme (ACE) inhibitors are a mainstay of antihypertensive therapy. Quinapril hydrochloride, a less commonly used, and less-studied ACE inhibitor has been approved for its primary use in hypertension.
Rahul Gupta +2 more
exaly +4 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The Clinical Pharmacokinetics of Quinapril
Angiology, 1989Quinapril (Q) and quinaprilat (QT) pharmacokinetics are dose pro portional following single oral 2.5- to 80-mg Q doses. Q absorption and hy drolysis to QT is rapid with peak Q and QT concentrations occurring one and two hours postdose, respectively.
Stephen C. Olson +6 more
openaire +2 more sources

